SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 44 filers reported holding SUTRO BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $145,925 | -86.3% | 18,060 | -90.6% | 0.00% | -85.0% |
| Q3 2022 | $1,064,000 | -25.1% | 191,721 | -29.7% | 0.02% | -48.7% |
| Q2 2022 | $1,421,000 | +171.7% | 272,764 | +328.8% | 0.04% | +178.6% |
| Q1 2022 | $523,000 | -53.4% | 63,610 | -15.7% | 0.01% | -60.0% |
| Q4 2021 | $1,122,000 | +458.2% | 75,412 | +463.0% | 0.04% | -62.8% |
| Q3 2018 | $201,000 | – | 13,395 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |